This week Liverpool is hosting the IP2023 (Infection Prevention) Annual Conference.
Held at the ACC Arena from the 17th – 19th October the role of the Infection Prevention Society is to inform, promote and sustain evidence-based infection prevention policy and practice, with a conference agenda that includes Antimicrobial Resistance, Preparedness and Environment, with a network of UK and International speakers.
The conference is a perfect fit for Liverpool City Region which has an established vaccine, biotech and wider life sciences ecosystem sitting alongside growing research, digital and clinical capabilities.
With world-leading institutes and facilities such as the Liverpool School of Tropical Medicine(LSTM), the Hartree Centre in Daresbury and the Materials Innovation Factory (MIF), Liverpool City Region’s vaccine and biopharmaceutical cluster provides the support and knowledge needed for the development, scale-up and commercialisation of vaccines and vaccine technology.
Home to innovative leaders in biopharma, biotech and vaccines including AstraZeneca, Seqirus, Bristol Myers Squibb, Pharmaron, TriRx, Teva and many more, the region is one of the UK’s largest life sciences hubs due to its dense, sustainable and highly integrated ecosystem.
To find out more about Liverpool City Region’s Infection Prevention and Control here